Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients
SAN DIEGO, Aug. 5 /PRNewswire/ -- Ceregene, Inc. today announced that the Michael J. Fox
Foundation will provide partial funds for long-term follow-up testing of patients enrolled in the company's Phase 2 trial of CERE-120 for Parkinson's disease. The funding will enable Ceregene t...
Micromet Adds Sir Walter Bodmer and Bernard Fox to Its Advisory Panel for BiTE Antibody Therapeutics
Appointments Strengthen Expertise in Immunotherapy of Cancer
BETHESDA, Md., March 19 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announ...
Michael J. Fox Foundation Commits Up To $5 Million for Pre-Clinical Drug Development Under Industry-Exclusive Therapeutics Development Initiative
NEW YORK, March 13 /PRNewswire-USNewswire/ -- The Michael J. Fox
Foundation for Parkinson's Research seeks applications from industry researchers under its $5-million Therapeutics Development Initiative (TDI). The Foundation also announced that, going forward, TDI will be launched bi-annually. A...
Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinson's Disease Target
SEATTLE, Jan. 6 /PRNewswire/ -- Omeros Corporation today announced that The Michael J. Fox
Foundation has awarded it a $465,000 grant against milestones to support the Company's collaboration with The Parkinson's Institute to evaluate Omeros' recent discovery of a new target for the treatment of P...
Michael J. Fox Foundation Awards $2 Million Grant From EMD Serono to Research Projects on Cognitive Deficits in Parkinson's Disease
- Five research teams selected to receive funding for preclinical and clinical research projects in Parkinson's disease-related cognitive deficits and mood disorders
ROCKLAND, Mass., Oct. 14 /PRNewswire/ -- The Michael J. Fox
for Parkinson's Research (MJFF) aw...
Molecular Biometrics Announces Results of Parkinson's Disease Research and Receipt of Grant From Michael J. Fox Foundation to Advance Diagnostic Technology
New research demonstrates proof-of-concept for diagnosing Parkinson's disease using non-invasive, biospectroscopy technology
Michael J. Fox
Foundation awards grant to Molecular Biometrics for further development of Parkinson's diagnostic
CHESTER, N.J. and MONTREAL, Au...
Zenobia Therapeutics, Inc. Receives Michael J. Fox Foundation for Parkinson's Research Award for Work on PD-implicated Protein LRRK2
LA JOLLA, Calif., July 29 /PRNewswire/ -- Zenobia Therapeutics, Inc.
(Zenobia) announced today that it has received a Therapeutics Development
Initiative award from The Michael J. Fox
Foundation for Parkinson's
Research. The program targets industry-based research with potential to
The Michael J. Fox Foundation Awards $2 Million to Shed Light on Role of LRRK2 and Alpha-Synuclein Genes in Parkinson's Disease
NEW YORK, Jan. 15 /PRNewswire-USNewswire/ --- The Michael J. Fox
Foundation for Parkinson's Research today announced approximately $2
million in total funding for seven research studies aiming to advance the
ability of the Parkinson's research field, and drug makers, to
therapeutically target ...
Glycominds and Fox Chase Cancer Center Announce a Collaboration to Discover New Cancer Detection Diagnostic Tests
LOD, Israel, October 25 /PRNewswire/ -- Glycominds Ltd., a
bio-diagnostics company specializing in glycan biomarkers for diagnosis and
disease management of autoimmune diseases and cancer, announced today
entering into a research agreement with Fox
Chase Cancer Center (FCCC), an
Michael J. Fox coming to UW Waisman Center
Madison, Wis. Actor Michael J. Fox
plans to visit the Waisman Center in Madison on Tuesday. Following the tour, Governor Jim Doyle and Fox
will hold a media event to discuss the Waisman Center and the governor's plans for biotechnology research in Wisconsin.
In November, Doyle outlined Wiscon...
Stem-cell research gets grant from M.J. Fox Foundation
Madison, Wis. Su-Chun Zhang received another boost to his stem-cell research from a grant awarded on Monday by the Michael J. Fox
Foundation . Zhang, an assistant professor of anatomy and neurology at the University of Wisconsin-Madisons stem-cell research program, will receive approximately $3...
Extreme Entrepreneur Tour coming to Fox Valley
Appleton, Wis. - Cramped living, microwave dinners, and tuition payments compel many college students to dream up creative ways to make money. And while inventiveness and business savvy flow naturally for some, every young capitalist needs a role model.
To fill this need, Fox
Sentry Insurance to add 30 IT jobs in Fox Valley
Stevens Point, Wis . - Representatives of Sentry Insurance are recruiting information technology workers to staff a new office that will open in the Fox
Valley earlier next year.
The Stevens Point-based insurer plans to expand its information technology operations in the valley, citing a ri...
Novel drug discovery tool could identify promising new therapies for Parkinson's disease
...for Parkinson's disease. The study received additional funding from NIH's National Institute of Environmental Health Sciences, and from the Michael J. fox
Foundation and the American Parkinson's Disease Association.
Parkinson's disease attacks cells in a part of the brain responsible for motor contro...
Television News Segment Featuring Pyratine XR to Air to 18 Million + Households on DIRECTV NewsCluster
...t on DIRECTV's NewsCluster. The NewsCluster includes Bloomberg, CNBC, CNN, fox
News, Headline News, MSNBC, fox
Business News, and The Weather Channel.
DIRECTV is America's #1 satel...
Life Science Leaders Discuss Strategies for Surviving the Financial Crisis at Yankee Public Relations Symposium
...anies pressed to the wall," said Jeffrey Nicholas, J.D. , a Partner at fox
Rothschild in Princeton. "They don't necessarily take a good measure of t... Smart Consulting , Managing Partner; and Vincent A. Vietti , J.D., fox
Rothschild , Partner.
Yankee Public Relations
Industry Professionals Get Schooled in Real-World Oncology Issues at NCCN Academy
...ana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Comprehensive Cancer Center, Durham, NC; fox
Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah , Salt Lake City, UT; Fred Hutchinson Cancer Research Cent...
Pharmaxis Builds Senior Management Team
Director, Dr Brett Charlton.
has more than 15 years experience in the internati...Executive Officer said: "The
appointment of Howard fox
provides the international regulatory and
pharmaco...ch looking forward to
who has just relocated from the United Kingdom wil...
Clinical Research Study Focuses on Little Known Behavioral Changes Related to Parkinson's Disease
...g the quality of life for people with Parkinson's disease and its behavioral complications. The company recently received an award from the Michael J. fox
Foundation for its continuing work in Parkinson's research.
ACADIA Pharmaceuticals is now evaluating an investigational medication that researche...
MyCancerPain.org Launched as Resource for Patients with Painful Bone Metastases
...e-stage cancer, including bone pain," said Andre A. Konski, MD, MBA,
MA, Director of Radiation Oncology Clinical Research and Chief Medical
Officer at fox
Chase Cancer Center. "As physicians, our goal is not only to
treat disease, but to help improve the quality of our patients' lives. We
look forward to...
Leading Canadian Scientist to speak at UN Climate Change Conference
...: Why Agriculture
Matters for the Climate Change Policy"
WHEN: Monday, December 8, 2008 between 7:30 p.m. - 9:00 p.m.
Dr. Dennis is available for interviews prior to his departure this week to the conference and for those media covering the UN conferenc...
Ceregene Announces Clinical Data From Phase 2 Clinical Trial of CERE-120 for Parkinson's Disease
...-120 from Ceregene, an agreement that was announced
in June 2007. Ceregene gratefully acknowledges the financial support received
from the Michael J. fox
Foundation for Parkinson's Research to help defray
some of the costs of the CERE-120 Phase 1 and Phase 2 clinical trials.
About Parkinson's Di...
Annual List of 'Best Doctors in Dallas' Showcases Texas Institute for Surgery Physicians
...ohn, MD Paul H. Ellenbogen, MD Cynthia S. Sherry, MD
Urology James Cochran, MD Brian A. Feagins, MD Joshua K. Fine, MD Steve M. Frost, MD Pat fox
Fulgham, MD L. Michael Goldstein, MD Michael B. Gross, MD Keith T. Kadesky, MD Meredith Lightfoot, MD Donald McKay, MD Mitchell Moskowitz, MD R...
MIGENIX Reports First Quarter Fiscal 2009 Financial Results
...o clinical trials.
MX-4565 (small molecule; treatment of neurodegenerative diseases): The
potential for a second year of funding from the Michael J. fox
("MJFF") to fund research in our MX-4565 program is under review by MJFF.
Our agreement with the MJFF provides us a relationship with Elan
Abeome Forms First Class Scientific Advisory Board
...uck brings 24 years of experience in directing creative science in
diverse areas of research.
Jeff Boyd, PhD, Chief Scientific Officer and Sr. VP at fox
Center in Philadelphia, has an international reputation as one of the
leading scientists in the study of molecular genetics of women's ca...
MIGENIX Corporate Update and Requisition of Special Meeting
...alties upon commercialization.
MX-4565 (for neurodegenerative diseases): This pre-clinical program has
been supported by a grant from the Michael J. fox
awarded to us in June 2007 for research related to Parkinson's and other
disease indications. The potential for a second year of f...
Christine Poon Will Keynote MichBio Expo
...cines (1998-2000) and President
of Medical Devices (1997-1998). She is a Director of Prudential Financial
Inc., the US-China Business Council, and the fox
Chase Cancer Center in
Philadelphia PA. Ms. Poon received her BA in Biology from Northwestern
University, her M.S. in Biology and Biochemistry from St...
Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia
...b mesylate) tablets prescribing information. East Hanover, NJ: Novartis Pharmaceuticals Corporation; Nov 2007.
Media Contacts Media Only: Kim fox
Novartis Oncology P: +1 862 778 7692 C: +1 917 415 2425
Dana Kahn Cooper P: +1 732 817 1800 C: +1 732 239 6664
Investors only: Jill Pozarek ...
Molecular changes in brain fluid give insight into brain-damaging disease
...ute, La Jolla, who developed an approach to identify molecular changes in the fluid bathing the CNS (the CSF). The researchers, who were led by Howard fox
and Gary Siuzdak, hope that similar approaches could be used to provide new information about other neurodegenerative and neuropsychiatric disorders. ...
Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595)
...so pleased to announce the
promotions of Drs. Judy fox
and Glenn Michelson. Judy and Glenn have made
trem...nsylvania and a B.A. from Boston University.
joined Sunesis in 2006 as Senior Director, Program...s novel oncology compounds. From 2002 to 2005, Dr. fox
Senior Director/Senior Staff Scientist for Gen...
Poniard Pharmaceuticals Appoints Four New Members to Clinical Advisory Board
... Colorado Comprehensive Cancer Center;
Robert F. Ozols, M.D., Ph.D., of the fox
Chase Cancer Center in
Philadelphia; and Everett E. Vokes, M.D., of the Uni... Angeles.
-- Robert F. Ozols, M.D., Ph.D., is senior vice president of fox
Chase Cancer Center in Philadelphia, where he oversees all of the Cente...
More Than 700 Physicians and Administrators Participate in the Visian ICL Growth Program(TM) Launch
...er Visian ICL surgeons has been featured on numerous shows
recently, including Dr. Steven Chang on ABC News in San Francisco, Dr.
Konrad Filutowski on fox
News in Orlando and Dr. William Goldstein on Fox
News in Detroit, while Dr. Paul Dougherty will be featured on an episode of
the "Modern Beauty Show" ...
Fight Melanoma, With Joe Pesci and Dennis Haysbert on Monday, April 21st
...on (Makin' It), Robert Hays
(Airplane), James Hyde (Passions), Kevin Weisman (Alias), Robert Torti
(Suite Life of Zack n' Cody), Dan Moriarty (Host -- fox
Regan Burns (Halfway Home), Alex Hyde-White (Pretty Woman), Jaime Gomez
(Nash Bridges), Denny Hocking (MLB-Twins), Pam Teeguarden (U...
Derma Sciences' MEDIHONEY(TM) Profiled in Several Television News Health Reports
...chronicled a Georgetown University
pilot program that is evaluating MEDIHONEY for wound care.
affiliate WTFX chronicled a similar program at Temple
MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results
...position in Spring
MX-4565 (small molecule; treatment of neurodegenerative diseases): In
June 2007 we were awarded a grant from the Michael J. fox
fund research in our MX-4565 program. Studies funded by the grant are
Other Matters: We provided notice to the University of ...
Raven Announces RAV12 Phase 1/2a Study Results To Be Presented at ASCO
...n, particularly those of gastrointestinal (GI) origin, was
conducted at 5 institutions in the US, the Sarah Cannon Cancer Center in
Nashville, TN; the fox
Chase Cancer Center in Philadelphia, PA; Premiere
Oncology in Santa Monica, CA; the University of Miami Medical Center in
Miami, FL; and the Georgetow...
Cord Blood America Subsidiary Featured at NASCAR Sprint Cup Series Race
...tured with their logo
prominent on car #49 at the Sunday, March 2, NASCAR UAW-Dodge 400 race at
Las Vegas Motor Speedway. The race was featured on the fox
"This is one of NASCAR's West Coast premiere races, an event racing
fans look forward to all year round and which was sold out for the seve...
Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs
... Center; Yale University; the University of Texas M. D.
Anderson Cancer Center; the Cambridge Institute for Medical Research and
MRC Cancer Cell Unit; fox
Chase Cancer Center; Harvard Medical School;
Stanford University School of Medicine; British Columbia Cancer Research
Centre; Trinity College, Dublin;...
Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
...protein folding and stabilization.
The company's advanced pre-clinical program in Parkinson's disease,
funded in part by a grant from the Michael J. fox
Foundation, will continue
with the potential to initiate clinical studies in 2008. In the fourth
quarter of 2007, the company announced pre-clinical r...
MIGENIX Reports Second Quarter Fiscal Year 2008 Financial Results
MX-4565 (small molecule; treatment of neurodegenerative diseases): In
June 2007 we were awarded a grant from the Michael J. fox
fund research in our MX-4565 program. The grant award agreement provides
Elan Pharmaceuticals with a limited right to license the techno...